Related references
Note: Only part of the references are listed.The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]
Jecko Thachil et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
Alexey S. Revenko et al.
BLOOD (2011)
Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative Bacterium Yersinia enterocolitica
Deyan Luo et al.
JOURNAL OF IMMUNOLOGY (2011)
Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytes
Asako Itakura et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Thrombin Mutant W215A/E217A Treatment Improves Neurological Outcome and Reduces Cerebral Infarct Size in a Mouse Model of Ischemic Stroke
Michelle A. Berny-Lang et al.
STROKE (2011)
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
Ophira Salomon et al.
THROMBOSIS AND HAEMOSTASIS (2011)
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
Qiufang Cheng et al.
BLOOD (2010)
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
Hong Zhang et al.
BLOOD (2010)
Polyphosphate exerts differential effects on blood clotting, depending on polymer size
Stephanie A. Smith et al.
BLOOD (2010)
Studies on Fletcher trait and Fitzgerald trait A rare chance to disclose body's defense reactions against injury
Hidehiko Saito
THROMBOSIS AND HAEMOSTASIS (2010)
Identification of Coagulation Factor XI as a Ligand for Platelet Apolipoprotein E Receptor 2 (ApoER2)
Tara C. White-Adams et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Erik I. Tucker et al.
BLOOD (2009)
Factor XI contributes to thrombin generation in the absence of factor XII
Dmitri V. Kravtsov et al.
BLOOD (2009)
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Ophira Salomon et al.
BLOOD (2008)
Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis
Erik I. Tucker et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Evolution of the contact phase of vertebrate blood coagulation
M. B. Ponczek et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats
William A. Schumacher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The intrinsic pathway of coagulation:: a target for treating thromboembolic disease?
D. Gailani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Targeting platelets in acute experimental stroke - Impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding
Christoph Kleinschnitz et al.
CIRCULATION (2007)
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and YII
Carine J. M. Doggen et al.
BLOOD (2006)
Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events
David T. Yang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
C Kleinschnitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
E Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis
IK Mullarky et al.
INFECTION AND IMMUNITY (2005)
Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates
A Gruber et al.
BLOOD (2003)
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever
ECM van Gorp et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
High levels of coagulation factor XI as a risk factor for venous thrombosis.
JCM Meijers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
